Pharma & Bio
Technology
CG MedTech Rises on Acquisition by Largest Shareholder, a Private Equity Firm… Hair Loss Stocks SAMIK PHARM. Co., LTD. and JW SHINYAK CORPORATION Also Up [Bio Spotlight]
On the 19th, among domestic pharmaceutical and biotech stocks, the share prices of Innosys(056090), #SAMIK PHARM. Co., LTD., and JW SHINYAK CORPORATION(067290)rose significantly. CG MedTech hit its da…
Lifestyle
Setting Their Sights on a Second Celltrion... The “Troika” of Small but Strong CDMOs Shining Amid an Earnings-Driven Market
The paradigm of the domestic pharmaceutical and biotech investment market is shifting. The era of an expectation-driven market—where market capitalization would fluctuate by trillions of won based on …
Business·Industry
Halozyme’s ‘Target Agreement’ vs. Alteogen Inc.’s ‘Compound Agreement’… Why Alteogen Inc. Is Smiling
Alteogen Inc.(196170)’s partner, Merck (MSD), has invalidated Halozyme’s MDASE patent in a Post-Grant Review (PGR) before the U.S. Patent Trial and Appeal Board (PTAB), removing a hurdle to Alteogen I…
Lifestyle
FC303 Narrowly Avoided Repeating Medy-Tox Inc.’s Mistakes… FutureChem Co., Ltd.: “Currently in Technology Transfer Negotiations with Two European Companies”
FutureChem Co., Ltd.(220100)has terminated its European technology transfer agreement for “FC303,” a radiopharmaceutical for prostate cancer diagnosis, even while covering the research and development…
Lifestyle
"Overcame the Cancer Barrier That Even Immunotherapy Couldn’t Break"… Will KOLON LIFE SCIENCE Inc. Shake Up the Head and Neck Cancer Treatment Market?
A tumor disappeared after just a single dose. This is the result of preclinical research on KLS-3021, which KOLON LIFE SCIENCE Inc.(102940)presented last April at the American Association for Cancer R…
Manufacturing
BL Pharmtech Shares Hit Upper Limit as Expectations Grow for Technology Transfer Deal [K-Bio Pulse]
On June 18, shares of BL PharmTech, JLK, and Raphas stood out in the domestic pharmaceutical and biotechnology stock market with strong gains. In particular, BL PharmTech surged to the daily price lim…
Manufacturing
'Expectations for Technology Transfer Grow'—B.A. Pharmtech Rises... JLK, Inc. and Raphas Co., Ltd. Also Up [Bio Spotlight]
On the 18th, the domestic pharmaceutical and biotech stock market saw notable gains in the share prices of BL Pharmtech(065170), JLK, Inc.(322510), and Raphas Co., Ltd.(214260). In particular, BL Phar…
Technology
Kim Kyu-tae, President of Pharos iBio Co., Ltd.: "Pushing Ahead with U.S. Clinical Trials for Solid Tumor Treatment... Currently Discussing Combination Therapy Trials with Big Pharma"
The business focus of the artificial intelligence (AI)-driven new drug development industry is evolving toward the clinical stage through technology transfers or joint development. A recent technology…
Technology
Novartis Dominates the Oral Weight-Loss Drug Market… Lilly’s “Foundayo” Faces a Tough Road in the Race to Catch Up
In the oral glucagon-like peptide-1 (GLP-1) market—considered the next battleground in the global obesity treatment market—Novo Nordisk is currently dominating the field. Eli Lilly is seeking a turnar…
Business·Industry
"Leading with Fine Chemicals, Moving from Active Pharmaceutical Ingredients to Advanced Materials"... Is the Transformation of Pamicell and Kukjeon Justified? [Dragon vs. Tiger: K-Bio]
Pharmaceutical and biotech companies are expanding their reach into markets for advanced industrial materials—such as artificial intelligence (AI), semiconductors, and electronic materials—by leveragi…